Drug against breast cancer is also highly potent against a frequent form of leukaemia

(University of Veterinary Medicine -- Vienna) Acute myeloid leukaemia (AML) is the most frequent form of blood cancer. In about 30 percent of AML patients, a mutation in the FLT3 tyrosine kinase accelerates the course of the disease. Common therapies were not successful in healing these patients so far. Researchers at the University of Veterinary Medicine, Vienna managed now to specifically target and kill AML cancer cells carrying this activating mutation. The study was published in the top hemato-oncology journal Blood.
Source: EurekAlert! - Biology - Category: Biology Source Type: news